Clinical trial · Observational
Feasibility of Integrating Homeopathic Approach in a Comprehensive Cancer Center
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Supportive and palliative care play an important role in cancer treatment, and when introduced early can improve quality of life and may even increase median survival rates, as shown in patients with advanced lung cancer. Complementary and integrative medicine (CIM) is a popular supportive approach among oncology patients and is on the rise worldwide. In many countries, homeopathy is being one the CIM methods integrated with a general sense that this treatment is beneficial to the well-being and quality of life (QoL) of cancer patients. In this observational study we will evaluate the feasibility of integrating homeopathic approach in patients attending the complementary and integrative oncology service at the division of oncology in Rambam Health Campus in Haifa, Israel, a major referral comprehensive cancer center. This observational study will evaluate three main ingredients of acceptance: * Obtaining the reasons that patients willing to integrate this supportive approach * Patient acceptance of this supportive approach as well as compliance with the homeopathic approach * Obtaining retrospective subjective information from the patients through validated quality of life questionnaires. (MYCaW, Distress Thermometer, and ESAS-R) Measures which are used routinely in integrative oncology encounters.
Conditions
Conditions (4)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
| Complementary Medicine | — | UNRESOLVED | — |
| Integrative Medicine | — | UNRESOLVED | — |
| Quality of Life | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Feasibility of a supportive approach | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Feasibility of a supportive approach
- description
- Evaluating a feasibility of an approach
- interventionNames
- Behavioral: Feasibility of a supportive approach
Primary outcomes (2)
- measure
- Feasibility of a supportive approach
- timeFrame
- 6-12 weeks
- description
- Questionnaire
- measure
- Quality of life- Level of Distress
- timeFrame
- 6-12 weeks
- description
- Distress thermometer
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * • 18 years of age or older * Ability to read, write, and understand the Hebrew language * Patients treated at the Division of Oncology in Rambam Health Campus. * Performance status of ECOG 0-2. * Consent to participate in the study. Exclusion Criteria: * • Inability to understand the intent of the study and follow the instructions * Diagnosis of active psychosis, altered mental state or severe cognitive impairment confirmed by the patient's attending physician. * Frailty, ECOG worse than 2, or other unstable medical conditions as confirmed by the patient's attending physician including acute illness, fever, unclear rash or medical conditions that would preclude participation in an interview session lasting 15-30 minutes
References
Publications (5)
- BACKGROUNDTheunissen I, Bagot JL. Supportive cancer care: is integrative oncology the future? Curr Opin Oncol. 2024 Jul 1;36(4):248-252. doi: 10.1097/CCO.0000000000001027. Epub 2024 Feb 23. PMID 38842016
- BACKGROUNDFrenkel M. Is There a Role for Homeopathy in Cancer Care? Questions and Challenges. Curr Oncol Rep. 2015 Sep;17(9):43. doi: 10.1007/s11912-015-0467-8. PMID 26210222
- BACKGROUNDFrass M, Lechleitner P, Grundling C, Pirker C, Grasmuk-Siegl E, Domayer J, Hochmair M, Gaertner K, Duscheck C, Muchitsch I, Marosi C, Schumacher M, Zochbauer-Muller S, Manchanda RK, Schrott A, Burghuber O. Homeopathic Treatment as an Add-On Therapy May Improve Quality of Life and Prolong Survival in Patients with Non-Small Cell Lung Cancer: A Prospective, Randomized, Placebo-Controlled, Double-Blind, Three-Arm, Multicenter Study. Oncologist. 2020 Dec;25(12):e1930-e1955. doi: 10.1002/onco.13548. Epub 2020 Nov 7. PMID 33010094
- BACKGROUNDDolev T, Ben-David M, Shahadi I, Freed Y, Zubedat S, Aga-Mizrachi S, Brand Z, Galper S, Jacobson G, Avital A. Attention Dysregulation in Breast Cancer Patients Following a Complementary Alternative Treatment Routine: A Double-Blind Randomized Trial. Integr Cancer Ther. 2021 Jan-Dec;20:15347354211019470. doi: 10.1177/15347354211019470. PMID 34027702
- BACKGROUNDSamuels N, Freed Y, Weitzen R, Ben-David M, Maimon Y, Eliyahu U, Berger R. Feasibility of Homeopathic Treatment for Symptom Reduction in an Integrative Oncology Service. Integr Cancer Ther. 2018 Jun;17(2):486-492. doi: 10.1177/1534735417736133. Epub 2017 Nov 2. PMID 29094627